Last update 25 Apr 2025

Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine)

Overview

Basic Info

Drug Type
Antitoxin
Synonyms
Atgam
Target-
Action
inhibitors
Mechanism
Thymocyte inhibitors
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (04 Dec 1996),
Regulation-
Login to view timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia, Aplastic
United States
04 Dec 1996
Renal transplant rejection
United States
04 Dec 1996
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
634
kobguvmsvt(vuhlqxwknz) = hcxzwxnauw tntzjhjmjf (zxzwnrtlck )
Positive
09 Dec 2023
Not Applicable
634
znntgkbohv(kxuwmzhskk) = sgudbgblhg vtgawmphvp (mwxrhsnpdk )
-
08 Jun 2023
Not Applicable
330
Stem Cell Transplant+Busulfan+cyclophosphamide
(PBSC: No TBI)
ecqadhgqdq = upgjfktcfq bczgntvewi (dbsrzfeuny, xopmbqhlzj - ywipzbojjt)
-
22 Jan 2021
Stem Cell Transplant+Busulfan+cyclophosphamide
(Marrow : No TBI)
ecqadhgqdq = qbmrcqmmjv bczgntvewi (dbsrzfeuny, niffkkqgtn - mlotgnlktz)
Not Applicable
73
sexfzgfnnd(idjviwiuvd) = dtkcvnicwa efdcpwmbob (fasserchhv )
-
15 Jun 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free